⚠ BETA β€” all market data shown (deals, filings, prices, indices) is demo / illustrative, not live trading data. For evaluation only; verify before acting.
June 17, 2026

NSE

Marksans Pharma LimitedMARKSANS

Marksans Pharma Limited is an Indian pharmaceutical company focused on manufacturing and marketing of generic drugs.

Key productsGeneric drugs, APIs (Active Pharmaceutical Ingredients)
GeographyIndia, Export markets in Southeast Asia, Middle East
CompetitorsDr Reddy's Laboratories, Cipla

AI-generated overview β€” verify before relying on it.

Net institutional flow

+β‚Ή371.1 Cr

Institutional buyers

8 in / 0 out

High-impact filings

1 Β· tilt Bullish

Next corporate action

Dividend - Re 0.80 Per Share

ex 2025-08-01

Competitive landscape β€” the read

vs most-traded names Β· 1Y
Institutional money is backing ATALREAL hardest (+β‚Ή15.1 Cr net). MARKSANS ranks #4 of 7 on flow (net buying +β‚Ή0 Cr). Filing momentum favours MARKSANS (+1).
#CompanyInst. flow β‚ΉCrDealsHi-impactFiling mom.BuzzNews
1ATALREAL+β‚Ή15.1 Cr267β€”β€”β€”β€”
2MOBIKWIK+β‚Ή5.2 Cr355β€”β€”β€”β€”
3MTNL+β‚Ή0.1 Cr26β€”β€”β€”β€”
4MARKSANSThisβ€”β€”1+1β€”β€”
5GATECHβˆ’β‚Ή0.3 Cr77β€”β€”β€”β€”
6IRMENERGYβˆ’β‚Ή2.2 Cr356β€”β€”β€”β€”
7QUADFUTUREβˆ’β‚Ή7.9 Cr177β€”β€”β€”β€”

Ranked by net institutional flow (buys βˆ’ sells, β‚ΉCr). Filing momentum = bullish βˆ’ bearish filings; Buzz = news+social sentiment. Curate peers in the company admin.

Timeline β€” MARKSANS day by day

Merged from deals, filings, corporate actions and news β€” newest first. Compact rolls each day up to net flow + counts. Scope with the range above.

Filings that matter

  • 7
    M&ABullish

    Acquisition update suggests growth strategy, positive for MARKSANS.

    Source PDF β†’
  • 2
    RatingNeutral

    India Ratings and Research has revised the outlook for the Company s bank loan facilities to Positive from Stable

    Source PDF β†’
  • 2
    Investor CallNeutral

    Schedule for Virtual Investor Conference

    Source PDF β†’

Bulk & block deals

No bulk/block deals for MARKSANS in this window.

Results & transcripts

News & chatter on MARKSANS

RSS News

0

No recent news.

Google News RSS β€” links open the source.

Investdesk

0

No articles yet.

Our coverage.

Reddit

0

No Reddit chatter.

r/ posts mentioning the company.

Twitter / X

0

No posts.

Posts mentioning the company.